Friday, 30 September 2022

Apollo Hospitals collaborates with Singapore-based ConnectedLife

06 July 2022 | News

For healthcare providers to be able to predict the risk of cardiac disease in their patients and initiate intervention early enough to make a real difference

Image Credit: Shutterstock

Image Credit: Shutterstock

Apollo Hospitals has announced a unique collaboration with Singapore-based ConnectedLife to integrate Apollo’s AICVD tool with ConnectedLife’s digital solutions for wellness, condition management and other health-focussed applications.

 

The AICVD tool can predict the risk of cardiovascular disease. This will empower healthcare providers with the tools to predict the risk of cardiac disease in their patients and initiate intervention early enough to make a real difference.

 

The clinical integration was demonstrated during the online event to announce the collaboration. The cardiac risk scoring tool is remarkable for its speed in processing data and accuracy in predicting the probability of a patient developing coronary disease. Using the tool, physicians are enabled to deliver proactive, pre-emptive and preventive care for at-risk individuals, improving lives, while mitigating future risks to life and lessening the pressure on healthcare systems.

 

The unique research and development collaboration between Apollo Hospitals and ConnectedLife will advance the application and capabilities by providing the AI with near real-time, continuous, longitudinal wellness and health data, e.g. breathing rate, heart rate, exercise, sedentary time, sleep, PROs, and as a result deliver a digital transformation from the point in time assessment to one that is continuous and dynamic in a remote, home setting.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account